Project Grant R21EY036560

Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $211K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Portland, OR 97232, USA
Similar Awards
This federal Project Grant award of $494,418.00 from the National Eye Institute (CFDA 93.867 - Vision Research) will support research to investigate the role of the visual environment in the development of myopia, or nearsightedness. The key objectives are: Determine the anti-myopia effectiveness of different real-world visual scenes to understand how the visual environment impacts eye growth and refractive development. Develop improved "repeated low-level red light" therapies that...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) will support research to investigate the role of retinal signaling pathways in the development of myopia, or nearsightedness. The $391,250 award to Emory University will fund a 5-year study to quantify changes in on and off retinal pathways in myopic eyes, determine how disrupting the balance between these pathways impacts myopia susceptibility, and evaluate the influence of ambient light levels on this...
This $148,568 Project Grant award from the National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), supports research at Emory University to investigate the role of scleral fibroblasts in refractive development and myopia. The primary objectives are to: 1) Identify characteristics of scleral fibroblasts in mouse eyes that undergo normal refractive development versus those exposed to myopic stimuli, and 2) Determine the role of retinoic acid signaling in driving...
The National Eye Institute (NEI) awarded a $433,125 federal Project Grant (CFDA 93.867 - Vision Research) to The Ohio State University to leverage data from the Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) study to address critical clinical questions in myopia control. The funded research aims to analyze axial length data to determine whom to treat and whether myopia control treatments are beneficial, assess the effects of time spent outdoors and sports...
This Project Grant award of $437,959 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research to develop, evaluate, and validate large language models (LLMs) for studying amblyopia treatment, adherence, and outcomes using electronic health record (EHR) data. The project aims to enable more research and the development of clinical decision support tools that leverage data from EHR clinical notes, which often contain inconsistent documentation of...
The National Eye Institute (NEI) awarded a $417,162 Project Grant under the Vision Research program (CFDA 93.867) to the University of Houston System to develop and apply a polarization-sensitive swept source optical coherence tomography (PS-SSOCT) system for 3D mapping of the birefringent properties of the posterior eye in a non-human primate model. The goal is to quantify changes in birefringence within the retina, optic nerve head, and lamina cribrosa in response to changes in intraocular...
The National Eye Institute (NEI) awarded a $240,000 Project Grant (CFDA 93.867 - Vision Research) to Baylor College of Medicine to conduct research focused on "Characterization of the Nascent Retinal Proteome Regulating Hippo Signaling During Damage." The project aims to use cell type-specific metabolic labeling and purification techniques to identify the immediate molecular regulators of the Hippo signaling pathway in muller glial cells of the damaged mouse retina. This information is...
This federal Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) provides $441,375.00 to The Regents of the University of California, Berkeley to explore pharmacological interventions for slowing the progression of myopia (nearsightedness) using a guinea pig animal model. The funded research will investigate the efficacy of topical treatments combining levodopa-carbidopa and atropine-levodopa-carbidopa in inhibiting defocus-induced myopia, and explore the underlying...
The National Eye Institute (NEI), through its Vision Research federal grant program (CFDA 93.867), awarded a $247,800 Project Grant to Oregon Health & Science University (OHSU) to develop novel tools to help diagnose and classify uveitis, a common cause of blindness in the United States. The project aims to (1) develop ultrahigh-resolution optical coherence tomography (OCT) for imaging the anterior and vitreous media of the eye, and (2) quantify and classify inflammation in the aqueous and...
The National Eye Institute (NEI) awarded a $624,230 Project Grant under the Vision Research program (CFDA 93.867) to the University of California, Los Angeles (UCLA) for the period of May 1, 2025 to April 30, 2029. The grant supports research to investigate the physiology of retinal degeneration and how the retina maintains visual processing as photoreceptors are lost. Key objectives include documenting changes in rod function and connectivity to bipolar cells, and exploring the plasticity and...

The National Eye Institute (NEI) awarded a Project Grant (CFDA 93.867 Vision Research) worth $210,534 to Legacy Emanuel Hospital & Health Center in Portland, Oregon. The grant, which runs from September 1, 2024 to August 31, 2026, will fund research to investigate the cellular, molecular, and structural alterations in the optic nerve head associated with the development and progression of juvenile myopia using a tree shrew model.

Key objectives of the project include assessing changes in axonal health, myelin, and immune cell infiltration in the optic nerve head, and correlating these micro-level alterations with tissue-level changes observed through optical coherence tomography (OCT) imaging. The University of Alabama at Birmingham received a $YND4PLMC9AN7 sub-award to conduct the experimental procedures to induce myopia in tree shrews, perform longitudinal in vivo OCT imaging and biometric measurements, and analyze the data. The research aims to advance the understanding of the pathogenesis of myopia and open new avenues for developing novel treatment strategies.

Generated 7/1/25, 3:11 AM